Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(R) pulmonary technology. In addition to the headquarters and research and manufacturing facilities in Cambridge, Massachusetts, the company has a manufacturing facility in Chelsea, Massachusetts and a research and manufacturing facility in Ohio.
CONTACT: Rebecca Peterson
Director, Investor Relations
Alkermes, Inc.
(617) 583-6378
URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.